DE69728415D1 - Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) - Google Patents

Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)

Info

Publication number: DE69728415D1
Authority: DE; Germany
Prior art keywords: kgf; growth factor; keratinocyte growth; products; variants
Prior art date: 1996-10-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69728415T

Other languages

English (en)

Other versions

DE69728415T2 (de

Inventor

Owens Narhi

D Osslund

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Swedish Orphan Biovitrum AB

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-15

Filing date

1997-10-15

Publication date

2004-05-06

1997-10-15 Application filed by Amgen Inc filed Critical Amgen Inc

2004-05-06 Application granted granted Critical

2004-05-06 Publication of DE69728415D1 publication Critical patent/DE69728415D1/de

2004-08-12 Publication of DE69728415T2 publication Critical patent/DE69728415T2/de

2017-10-16 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Toxicology (AREA)
Pulmonology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DE69728415T 1996-10-15 1997-10-15 Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) Expired - Lifetime DE69728415T2 (de)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US2849396P	1996-10-15	1996-10-15
US28493P		1996-10-15
US3278196P	1996-12-06	1996-12-06
US32781P		1996-12-06
US3304696P	1996-12-11	1996-12-11
US33046P		1996-12-11
PCT/US1997/018607 WO1998016642A1 (en)	1996-10-15	1997-10-15	Keratinocyte growth factor-2 products

Publications (2)

Publication Number	Publication Date
DE69728415D1 true DE69728415D1 (de)	2004-05-06
DE69728415T2 DE69728415T2 (de)	2004-08-12

Family

ID=27363281

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE69728415T Expired - Lifetime DE69728415T2 (de)	1996-10-15	1997-10-15	Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
DE19781038T Withdrawn DE19781038T1 (de)	1996-10-15	1997-10-15	Keratinozytenwachstumsfaktor-2-Produkte

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE19781038T Withdrawn DE19781038T1 (de)	1996-10-15	1997-10-15	Keratinozytenwachstumsfaktor-2-Produkte

Country Status (12)

Country	Link
EP (1)	EP0935652B1 (de)
JP (2)	JP2001506975A (de)
AT (1)	ATE263239T1 (de)
AU (1)	AU727678C (de)
CA (1)	CA2269077C (de)
DE (2)	DE69728415T2 (de)
DK (1)	DK0935652T3 (de)
ES (1)	ES2218666T3 (de)
GB (1)	GB2322132B (de)
HK (1)	HK1022714A1 (de)
PT (1)	PT935652E (de)
WO (1)	WO1998016642A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6077692A (en) *	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
EP0950100B1 (de) *	1996-08-13	2004-02-11	Human Genome Sciences, Inc.	Mutanten des KERATINOCYTEN-WACHSTUMSFAKTOR-2 (KGF-2 ODER FIBROBLASTENWACHSTUMSFAKTOR-12,FGF-12)
SI0941110T1 (en) *	1996-10-15	2004-06-30	Amgen Inc.	Uses of keratinocyte growth factor-2
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
KR20010033484A (ko)	1997-12-22	2001-04-25	휴먼 게놈 사이언시즈, 인크.	각질세포 성장 인자-2 제제
US6372494B1 (en)	1999-05-14	2002-04-16	Advanced Tissue Sciences, Inc.	Methods of making conditioned cell culture medium compositions
CA2375829A1 (en) *	1999-06-02	2000-12-07	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
AU5911700A (en) *	1999-07-02	2001-01-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
JP3966819B2 (ja) *	2001-05-24	2007-08-29	キム，スーギョン	毛嚢に存在する新規の第２ケラチノサイト成長因子類似体
NZ530481A (en) *	2001-06-07	2007-11-30	Skinmedica Inc	Compositions comprising cell culture medium conditioned by cells grown in three-dimensional culture

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9407035A (pt) *	1993-06-29	1996-03-12	Chiron Corp	Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme
AU689214B2 (en) *	1994-02-01	1998-03-26	United States Of America, Represented By The Secretary, Department Of Health And Human Services, The	Fusion proteins that include antibody and nonantibody portions
HUT78069A (hu) *	1994-10-13	1999-08-30	Amgen Inc.	Keratinocita növekedési faktor analógok
EE03975B1 (et) *	1994-10-13	2003-02-17	Amgen Inc.	Keratinotsüüdi kasvufaktori analoogid
EP0815115B1 (de) *	1995-02-14	2003-05-28	Human Genome Sciences, Inc.	Keratinozyten-wachstumsfaktor 2
EP0950100B1 (de) *	1996-08-13	2004-02-11	Human Genome Sciences, Inc.	Mutanten des KERATINOCYTEN-WACHSTUMSFAKTOR-2 (KGF-2 ODER FIBROBLASTENWACHSTUMSFAKTOR-12,FGF-12)

1997
- 1997-10-15 DE DE69728415T patent/DE69728415T2/de not_active Expired - Lifetime
- 1997-10-15 DE DE19781038T patent/DE19781038T1/de not_active Withdrawn
- 1997-10-15 WO PCT/US1997/018607 patent/WO1998016642A1/en active IP Right Grant
- 1997-10-15 EP EP97910119A patent/EP0935652B1/de not_active Expired - Lifetime
- 1997-10-15 AU AU47576/97A patent/AU727678C/en not_active Ceased
- 1997-10-15 CA CA002269077A patent/CA2269077C/en not_active Expired - Fee Related
- 1997-10-15 PT PT97910119T patent/PT935652E/pt unknown
- 1997-10-15 AT AT97910119T patent/ATE263239T1/de active
- 1997-10-15 DK DK97910119T patent/DK0935652T3/da active
- 1997-10-15 JP JP51856598A patent/JP2001506975A/ja active Pending
- 1997-10-15 GB GB9811279A patent/GB2322132B/en not_active Revoked
- 1997-10-15 ES ES97910119T patent/ES2218666T3/es not_active Expired - Lifetime
2000
- 2000-02-17 HK HK00100939A patent/HK1022714A1/xx not_active IP Right Cessation
2008
- 2008-06-16 JP JP2008157291A patent/JP2008283980A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
EP0935652B1 (de)	2004-03-31
ATE263239T1 (de)	2004-04-15
GB2322132A (en)	1998-08-19
JP2008283980A (ja)	2008-11-27
GB9811279D0 (en)	1998-07-22
AU727678B2 (en)	2000-12-21
PT935652E (pt)	2004-07-30
AU4757697A (en)	1998-05-11
HK1022714A1 (en)	2000-08-18
WO1998016642A1 (en)	1998-04-23
DK0935652T3 (da)	2004-07-26
CA2269077A1 (en)	1998-04-23
CA2269077C (en)	2004-04-06
EP0935652A1 (de)	1999-08-18
DE19781038T1 (de)	1998-12-10
JP2001506975A (ja)	2001-05-29
ES2218666T3 (es)	2004-11-16
DE69728415T2 (de)	2004-08-12
AU727678C (en)	2005-05-12
GB2322132B (en)	1999-09-22

Publication	Publication Date	Title
BG102071A (en)	1998-09-30	Minor molecule inhibitors of rotamase enzymic activity
ATE286126T1 (de)	2005-01-15	Glialmitogene faktoren, ihre herstellung und verwendung
DE69029657D1 (de)	1997-02-20	Menschliches cytokin, interleukin-9
IL117425A0 (en)	1996-07-23	Receptor activation by gas6
DE69942459D1 (de)	2010-07-15	Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
RU94046367A (ru)	1997-03-27	Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела
ATE449850T1 (de)	2009-12-15	Mutanten von flt3-l und ihre verwendungen
ES2133813T3 (es)	1999-09-16	Cadenas de lamininas: diagnostico y uso terapeutico.
ATE263239T1 (de)	2004-04-15	Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
ATE256740T1 (de)	2004-01-15	Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
WO1997026322A3 (en)	1997-08-28	Methods and compositions for inhibiting hexokinase
HUT43106A (en)	1987-09-28	Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DK1082423T3 (da)	2006-02-13	Cyclin E2-gener og -proteiner
DE69808475D1 (de)	2002-11-07	Aminosäurederivate zur behandlung von schlaganfall
DK0977859T3 (da)	2004-12-06	Den neurotrofiske faktor NNT-1
ES2117717T3 (es)	1998-08-16	Tratamiento de tumores con factores neurotroficos e inhibidores de la proliferacion celular.
DE69838615D1 (de)	2007-12-06	ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
ATE205538T1 (de)	2001-09-15	Genregulatorische sequenzen von cd4, welche spezifisch in reifen t-zellen exprimiert werden
ATE389014T1 (de)	2008-03-15	Phosphorylierte glyoxalase i und deren verwendung
SE9604439D0 (sv)	1996-12-02	New receptor
FR2654430B1 (fr)	1995-01-06	Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
DK143984D0 (da)	1984-02-29	Nitrogenkilde til organismer
MXPA04004262A (es)	2004-07-08	Delta-1-pirrolinas.
WO2000061750A3 (en)	2001-12-06	TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
AU4210900A (en)	2000-11-14	Products and methods for treating ptp lar related diseases

Legal Events

Date	Code	Title	Description
2005-04-28	8364	No opposition during term of opposition
2010-07-01	8327	Change in the person/name/address of the patent owner	Owner name: BIOVITRUM AB (PUBL), STOCKHOLM, SE